Does ROTIGOTINE Cause Off label use? 646 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 646 reports of Off label use have been filed in association with ROTIGOTINE (Neupro). This represents 8.2% of all adverse event reports for ROTIGOTINE.
646
Reports of Off label use with ROTIGOTINE
8.2%
of all ROTIGOTINE reports
146
Deaths
208
Hospitalizations
How Dangerous Is Off label use From ROTIGOTINE?
Of the 646 reports, 146 (22.6%) resulted in death, 208 (32.2%) required hospitalization, and 6 (0.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROTIGOTINE. However, 646 reports have been filed with the FAERS database.
What Other Side Effects Does ROTIGOTINE Cause?
Product adhesion issue (1,718)
Drug ineffective (632)
Death (595)
Parkinson's disease (419)
Fall (412)
Device adhesion issue (383)
Overdose (353)
Application site pruritus (334)
Application site erythema (330)
Hallucination (258)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ROTIGOTINE Alternatives Have Lower Off label use Risk?
ROTIGOTINE vs ROXADUSTAT
ROTIGOTINE vs ROXICODONE
ROTIGOTINE vs ROXITHROMYCIN
ROTIGOTINE vs ROZANOLIXIZUMAB
ROTIGOTINE vs ROZANOLIXIZUMAB-NOLI